BPC-157 + KPV – 30 Capsules

The Promise: Dual-Pathway Gut and Mucosal Support

BPC-157 + KPV combines two investigational peptides in a convenient oral format for practitioner-directed protocols exploring intestinal-barrier integrity, mucosal recovery and inflammatory signalling. Each capsule contains 0.5mg BPC-157 and 0.5mg KPV.

Clear Benefits

• Gut-Barrier Research: Designed for protocols investigating the maintenance and recovery of the gastrointestinal lining.
• Inflammatory-Signalling Support: KPV has demonstrated effects on inflammatory pathways in laboratory and animal research.
• Complementary Peptide Strategy: Combines BPC-157’s preclinical tissue-repair research with KPV’s preclinical inflammation-focused research.
• Convenient Oral Delivery: A precisely portioned capsule provides both peptides without the complexity of separate products.

Medical Mechanism

• BPC-157 and Mucosal Repair: Animal studies have investigated BPC-157’s influence on nitric-oxide signalling, blood-vessel recruitment and gastrointestinal tissue repair.
• KPV and NF-κB Signalling: Cell and mouse studies suggest that KPV can enter intestinal cells through the PepT1 transporter and inhibit NF-κB and MAP-kinase inflammatory signalling.
• Dual Research Pathway: The combination is intended to explore both structural mucosal recovery and the regulation of inflammatory signalling. The combined formulation itself has not been validated in human trials.

Important: BPC-157 and KPV are investigational. Human safety and efficacy have not been established for this combination.